+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Insulin"

From
PRV-031 Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

PRV-031 Drug Insight and Market Forecast - 2032

  • Report
  • November 2023
  • 30 Pages
  • Global
From
RYZODEG Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

RYZODEG Drug Insight and Market Forecast - 2032

  • Report
  • November 2023
  • 30 Pages
  • Global
From
LEVEMIR Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

LEVEMIR Drug Insight and Market Forecast - 2032

  • Report
  • November 2023
  • 30 Pages
  • Global
From
From
Lipodystrophy - Epidemiology Forecast - 2032 - Product Thumbnail Image

Lipodystrophy - Epidemiology Forecast - 2032

  • Report
  • February 2023
  • 50 Pages
  • Global
From
Insulin Glargine- - Biosimilar Insight, 2022 - Product Thumbnail Image

Insulin Glargine- - Biosimilar Insight, 2022

  • Report
  • January 2022
  • 90 Pages
  • Global
From
Somatotropin - Biosimilar Insight, 2022 - Product Thumbnail Image

Somatotropin - Biosimilar Insight, 2022

  • Report
  • January 2022
  • 70 Pages
  • Global
From
United Kingdom Diabetes Market Report: 2024-2032 - Product Thumbnail Image

United Kingdom Diabetes Market Report: 2024-2032

  • Report
  • July 2024
  • 125 Pages
  • United Kingdom
From
United States Diabetes Market Report: 2024-2032 - Product Thumbnail Image

United States Diabetes Market Report: 2024-2032

  • Report
  • July 2024
  • 139 Pages
  • United States
From
Germany Diabetes Market Report: 2024-2032 - Product Thumbnail Image

Germany Diabetes Market Report: 2024-2032

  • Report
  • July 2024
  • 134 Pages
  • Germany
From
Russia Diabetes Market Report: 2024-2032 - Product Thumbnail Image

Russia Diabetes Market Report: 2024-2032

  • Report
  • July 2024
  • 133 Pages
  • Russia
From
China Diabetes Market Report: 2024-2032 - Product Thumbnail Image

China Diabetes Market Report: 2024-2032

  • Report
  • July 2024
  • 131 Pages
  • China
From
Japan Diabetes Market Report: 2024-2032 - Product Thumbnail Image

Japan Diabetes Market Report: 2024-2032

  • Report
  • July 2024
  • 138 Pages
  • Japan
From
Saudi Arabia Diabetes Market Report: 2024-2032 - Product Thumbnail Image

Saudi Arabia Diabetes Market Report: 2024-2032

  • Report
  • July 2024
  • 124 Pages
  • Saudi Arabia
From
Turkey Diabetes Market Report: 2024-2032 - Product Thumbnail Image

Turkey Diabetes Market Report: 2024-2032

  • Report
  • July 2024
  • 136 Pages
  • Turkey
From
Canada Diabetes Market Report: 2024-2032 - Product Thumbnail Image

Canada Diabetes Market Report: 2024-2032

  • Report
  • July 2024
  • 128 Pages
  • Canada
From
France Diabetes Market Report: 2024-2032 - Product Thumbnail Image

France Diabetes Market Report: 2024-2032

  • Report
  • July 2024
  • 140 Pages
  • France
From
Brazil Diabetes Market Report: 2024-2032 - Product Thumbnail Image

Brazil Diabetes Market Report: 2024-2032

  • Report
  • July 2024
  • 138 Pages
  • Brazil
From
Italy Diabetes Market Report: 2024-2032 - Product Thumbnail Image

Italy Diabetes Market Report: 2024-2032

  • Report
  • July 2024
  • 128 Pages
  • Italy
From
Loading Indicator

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump. The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more